Pfizer Sues Watson Over Embeda Generic

Law360, New York (October 7, 2011, 12:22 PM EDT) -- Pfizer Inc. lodged a patent infringement suit against Watson Pharmaceuticals Inc. and its subsidiaries in Delaware on Thursday in an effort to block it from selling a generic version of painkiller Embeda, a morphine-containing capsule designed to dissuade drug abuse.

The plaintiff filed the complaint after receiving notice in August that Watson had submitted an abbreviated new drug application to the U.S Food and Drug Administration seeking approval to manufacture and sell a generic version of Embeda.

The suit alleges that Watson's ANDA infringes three patents...
To view the full article, register now.